Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
28.95%
Operating Margin
18.29%
Net Margin
8.92%
Efficiency Metrics
Revenue per Expense Ratio
1.22
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
72.19%
Income Tax Rate
1.99%
EPS
0.0820000000
Balance Sheet Analysis
Current Ratio
3.12
Cash Ratio
2.42
Working Capital
$288.26M
Debt to Equity
0.75
Debt to Assets
39.67%
Equity Ratio
53.24%
Cash Flow Analysis
Operating Cash Flow Ratio
61.51%
Free Cash Flow Ratio
56.24%
CapEx to Revenue
5.27%
Dividends Paid
$151.93M
Stock Buybacks
$2.66M
Total Shareholder Returns
$154.59M
Cash Position Change
265.95%
Key Takeaways (2023 FY)
Increased dividend payments by 2.84%
Detailed Growth Metrics
Core Performance
Revenue
5.99%
Net Income
-73.30%
EPS
-78.42%
Operating Income
144.66%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
-6.15%
Operating Cash Flow
7.81%
Free Cash Flow
18.43%
Balance Sheet Health
Assets
3.43%
Debt
20.05%
Book Value per Share
-8.63%
Inventory
100.00%
Shareholder Returns
Dividends per Share
2.84%
Shares Outstanding
3.70%
Long Term Trends
3Y Revenue/Share
-5.24%
5Y Revenue/Share
-29.77%
3Y Dividend/Share
18.02%
5Y Dividend/Share
-29.42%